Executive Misconduct and Governance Failures
Two co-founders of Fullerton Healthcare Corporation (FHC), Dr. Daniel Chan Pai Sheng and Dr. Michael Tan Kim Song, were fined a combined S$160,000 on July 10, 2026, following their guilty pleas to charges of falsifying company accounts. The case, which centered on over S$211,000 in inflated entertainment expense claims, has exposed significant lapses in internal corporate governance.
Dr. Chan, the former deputy group CEO, received a fine of S$135,000 for five counts of falsification of accounts. Dr. Tan, the former group CEO, was fined S$25,000 for approving a specific falsified claim. Both men were granted a discharge not amounting to an acquittal regarding previous graft-related charges brought by the Corrupt Practices Investigation Bureau.
The Mechanism of Fraud
Court documents revealed that the inflated claims were used to funnel money to Collin Chiew, the former CEO of Aon Singapore, under the guise of consultancy services and financial assistance. Between 2015 and 2019, Dr. Chan submitted falsified or inflated KTV entertainment receipts after business trips to China and Hong Kong.
District Judge Paul Quan noted that the corporate structure allowed the executives to effectively bypass the finance department, as they held the authority to approve their own business expenses. “The group effectively checked itself,” the judge remarked, emphasizing that the lack of external oversight within the executive tier made the fraudulent activities difficult to detect for years.
Broader Legal Implications
While the sentencing marks a conclusion to the immediate charges against the co-founders, the legal fallout continues. Former FHC co-founder David Sin was previously fined S$160,000 in August 2025 for his role in the same scheme. Meanwhile, the case against former Aon Singapore CEO Collin Chiew, who remains accused of bribery and money laundering, is ongoing, with proceedings expected to continue later this month.